Abstract A045: Integrated tumor genomics and peripheral immune profiling identify complementary biomarkers of response to frontline pembrolizumab in extranodal NK/T-cell lymphoma
Year: 2026
Type: conference-abstract
Source: Blood Cancer Discovery
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7165755893
Cites:
Cited by:
Related to:
